The Audentes Therapeutics brand, founded in 2013 (United States), from 67 sister brands and 17477 competing brands. Audentes Therapeutics is owned by Astellas Pharma, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is JP3942400007. The sector of Audentes Therapeutics is Drug Manufacturers.

Audentes Therapeutics is a brand of Astellas Pharma (YPH) Share price

Date created : 2013 Business sector Drug Manufacturers

Share price and profitability of the share Astellas Pharma (Audentes Therapeutics)

Buy Astellas Pharma share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 8.70

Portfolio valuation
Astellas Pharma (Audentes Therapeutics) over 5 years* EUR 6.34

Stock market history Astellas Pharma (Audentes Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Astellas Pharma

Ogeda
Ogeda
Mitobridge
Mitobridge
Agensys
Agensys
ASTELLAS
ASTELLAS
See more brands of Astellas Pharma

Rival brands
Audentes Therapeutics

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS